학술논문

PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer
Document Type
article
Source
Cell Reports. 22(7)
Subject
Autoimmune Disease
Digestive Diseases
Inflammatory Bowel Disease
Cancer
Aetiology
2.1 Biological and endogenous factors
Inflammatory and immune system
Oral and gastrointestinal
Acute Disease
Adult
Aged
Animals
CARD Signaling Adaptor Proteins
Cell Line
Cell Membrane
Colitis
Colonic Neoplasms
Gene Deletion
Humans
Inflammasomes
Inflammation
Integrases
Interleukin-10
Interleukin-1alpha
Interleukin-1beta
Intestines
JNK Mitogen-Activated Protein Kinases
Macrophages
Mice
Middle Aged
Myeloid Cells
Protein Tyrosine Phosphatase
Non-Receptor Type 2
Tumor Burden
IBD
TC-PTP
colitis
inflammasome
inflammatory bowel disease
interleukin-1-alpha
Biochemistry and Cell Biology
Medical Physiology
Language
Abstract
Variants in the gene locus encoding protein tyrosine phosphatase non-receptor type 2 (PTPN2) are associated with inflammatory disorders, including inflammatory bowel diseases, rheumatoid arthritis, and type 1 diabetes. The anti-inflammatory role of PTPN2 is highlighted by the fact that PTPN2-deficient mice die a few weeks after birth because of systemic inflammation and severe colitis. However, the tissues, cells, and molecular mechanisms that contribute to this phenotype remain unclear. Here, we demonstrate that myeloid cell-specific deletion of PTPN2 in mice (PTPN2-LysMCre) promotes intestinal inflammation but protects from colitis-associated tumor formation in an IL-1β-dependent manner. Elevated levels of mature IL-1β production in PTPN2-LysMCre mice are a consequence of increased inflammasome assembly due to elevated phosphorylation of the inflammasome adaptor molecule ASC. Thus, we have identified a dual role for myeloid PTPN2 in directly regulating inflammasome activation and IL-1β production to suppress pro-inflammatory responses during colitis but promote intestinal tumor development.